Our investigations demonstrate that TOPK directly interacts with CHK1 and Cdc25C during cell-cycle progression, and that suppression of TOPK leaves cancer cells vulnerable to DNA damage during CHK1-mediated checkpoint activation. This evidence concerns the gene CDC25C and cancer.